Balancing impacts through responsible business practices, supply chains and energy use.
POSTED
04-18-06
POSTED
04-18-06
POSTED
04-18-06
POSTED
04-18-06
that it has recently received approval from the U.S. Food and Drug Administration (FDA) on
its new AVIVA premium line of intravenous solutions and plans to begin a limited launch of
...
POSTED
04-17-06
POSTED
04-17-06
POSTED
04-17-06
POSTED
04-17-06
POSTED
04-13-06